CAROLINE SUTTON: Open Payments
NPI 1780266643 · GREENWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,632 in 122 payments from 20 companies in 2025. Trend: 2023 $1,505 · 2024 $1,307 · 2025 $2,632
Food & beverage: $2,632
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 20 | $482 |
| Janssen Biotech, Inc. | 20 | $449 |
| ABBVIE INC. | 20 | $336 |
| GENZYME CORPORATION | 8 | $174 |
| Lilly USA, LLC | 6 | $155 |
| Regeneron Healthcare Solutions, Inc. | 5 | $148 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| LEO Pharma Inc. | 6 | $113 |
| Botanix SB Inc | 4 | $89 |
| Amgen Inc. | 3 | $78 |
Products named: OPZELURA, TREMFYA, DUPIXENT, SKYRIZI, EBGLYSS, COSENTYX, ADBRY, SOFDRA.
Industry payments across CT — which companies pay providers there.
